Form 4 for OGN Organon & Co.
Accepted 2023-04-04 00:00:00 ET · period of report 2023-03-31 · accession 0001209191-23-023089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-03-31 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | M - OptEx | $0.00 | +7,419 | 12.9K | +135% | $0 |
| D | 2023-04-04 | 2023-03-31 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | F - Tax | $23.09 | -2,115 | 10.8K | -16% | -$48.8K |
| D | 2023-04-04 | 2023-03-31 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | A - Grant | $0.00 | +66.8K | 66.8K | New | $0 |
| D | 2023-04-04 | 2023-03-31 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | M - OptEx | $0.00 | -7,419 | 14.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | M | A | 7,419 | $0.00 | 12,900 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-31 | F | D | 2,115 | $23.09 | 10,785 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-03-31 | A | A | 66,793 | $0.00 | 66,793 | D | $23.52 · 2024-03-31 to 2033-03-31 | 66,793 Common Stock | (F3) The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |
| 4 | Derivative | Restricted Stock Units | 2023-03-31 | M | D | 7,419 | $0.00 | 14,838 | D | — · — to — | 7,419 Common Stock | (F1) Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. (F2) On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. |